Physician
Eaton Pediatrics & Medical Corp.
Eaton Pediatrics & Medical Corp. was paid $2.69M by Medicaid between Jan 2018 and Oct 2024, across 48 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoEATON PEDIATRICS & MEDICAL CORP.
TRACY, CA 95376
TRACY, CA 95376
33aNPI1336249713assigned 09/25/2006
33bProvider typePediatrics Physician
28Total paid$2.69M
24GClaims107,661
24DCodes billed48
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#53 of 1,490
Median peer was paid$15K
This provider vs. median179×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,435 | $482K | |
| 2019 | 20,458 | $462K | |
| 2020 | 11,794 | $300K | |
| 2021 | 20,293 | $523K | |
| 2022 | 15,905 | $429K | |
| 2023 | 9,503 | $250K | |
| 2024incomplete | 9,273 | $240K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 16,512 | 15,201 | $759K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 20,014 | 18,477 | $609K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 7.6% | 12,050 | 11,863 | $205K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.2% | 3,394 | 3,366 | $168K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.8% | 2,539 | 2,519 | $156K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 3,359 | 3,334 | $142K |
| G9920 | Screening performed and negative | 4.1% | 3,540 | 3,528 | $110K |
| 97802 | 4.1% | 3,337 | 3,274 | $110K | |
| D1206 | Topical application of fluoride varnish | 3.9% | 4,433 | 4,388 | $105K |
| 92551 | 2.9% | 6,601 | 6,537 | $78K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 1,474 | 1,450 | $57K |
| 99401 | 1.8% | 2,611 | 2,604 | $50K |
36 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 335 | $23K |
| 99173 | <1% | 5,884 | $20K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 223 | $15K |
| 81002 | <1% | 5,342 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,758 | $12K |
| 99188 | <1% | 537 | $11K | |
| 92552 | <1% | 457 | $8K | |
| 96127 | <1% | 1,023 | $5K | |
| 90651 | <1% | 1,074 | $5K | |
| 90670 | <1% | 1,438 | $4K | |
| 90716 | <1% | 967 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 52 | $3K |
| 90734 | <1% | 751 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 63 | $2K |
| 90707 | <1% | 816 | $2K | |
| 90686 | <1% | 2,535 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| 90621 | <1% | 153 | $1K | |
| 90698 | <1% | 767 | $1K | |
| 90715 | <1% | 510 | $961.43 | |
| 90680 | <1% | 604 | $764.09 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 37 | $523.86 |
| 90697 | <1% | 90 | $495.47 | |
| 90696 | <1% | 228 | $452.01 | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 14 | $414.70 |
| 90633 | <1% | 802 | $348.40 | |
| 90744 | <1% | 394 | $252.71 | |
| 90700 | <1% | 195 | $159.02 | |
| 90685 | <1% | 487 | $155.84 | |
| 94760 | <1% | 14 | $79.95 | |
| 90713 | <1% | 54 | $38.21 | |
| 90648 | <1% | 52 | $13.54 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 34 | $1.32 |
| 90656 | 0% | 58 | $0.00 | |
| 90619 | 0% | 13 | $0.00 | |
| 90677 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDE LA CRUZ, MANUEL (PRESIDENT)